1527-3350/asset/cover.gif?v=1&s=3cd983af6575c8dbfd6b47a63ffa95415ace15f8 "Hepatology")
These authors contributed equally to this work.
1527-3350/asset/olbannerleft.gif?v=1&s=4b2409f9534ed500d3c8da1940a23842e2b9932d)
1527-3350/asset/olbannerright.gif?v=1&s=141b9a8485298533c3e2016e937b0404f7d933e1)
Viral Hepatitis
You have full text access to this OnlineOpen article
Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain†
Article first published online: 6 APR 2009
DOI: 10.1002/hep.23011
Copyright © 2009 American Association for the Study of Liver Diseases
Additional Information
How to Cite
Gao, B., Duan, Z., Xu, W. and Xiong, S. (2009), Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain. Hepatology, 50: 424–433. doi: 10.1002/hep.23011
- †
Potential conflict of interest: Nothing to report.
Publication History
- Issue published online: 29 JUL 2009
- Article first published online: 6 APR 2009
- Accepted manuscript online: 6 APR 2009 12:00AM EST
- Manuscript Accepted: 26 MAR 2009
- Manuscript Received: 23 NOV 2008
Funded by
- National Natural Science Foundation of China. Grant Numbers: 30872355, 30890141
- Major State Basic Research Development Program of China. Grant Number: 2007CB512401
- Shanghai STCSM. Grant Numbers: 07QA14005, 08JC1401200
- China 863. Grant Number: 2006AA02Z403
- Program for Outstanding Medical Academic Leader. Grant Number: LJ06011
References
- 1, . Hepatitis B virus infection—natural history and clinical consequences. N Engl J Med 2004; 350: 1118–1129.
- 2, . Hepatitis B virus biology. Microbiol Mol Biol Rev 2000; 64: 51–68.
- 3, , , . Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J Virol 2005; 79: 7269–7272.
- 4, , , , , , et al. Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication. HEPATOLOGY 2006; 43: 1364–1374.Direct Link:
- 5, , , , . Inhibition of hepatitis B virus replication by APOBEC3G. Science 2004; 303: 1829.
- 6, , . TRIM family proteins: retroviral restriction and antiviral defence. Nat Rev Microbiol 2005; 3: 799–808.
- 7, , , . TRIM family proteins and their emerging roles in innate immunity. Nat Rev Immunol 2008; 8: 849–860.
- 8, , , , , . The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004; 427: 848–853.
- 9, , . Restriction of an extinct retrovirus by the human TRIM5alpha antiviral protein. Science 2007; 316: 1756–1758.
- 10, , . The interferon response inhibits HIV particle production by induction of TRIM22. PLoS Pathog 2008; 4: e1000007.
- 11, , , , , . PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator. EMBO J 2001; 20: 3495–3505.
- 12, . TRIM28 mediates primer binding site-targeted silencing of murine leukemia virus in embryonic cells. Cell 2007; 131: 46–57.
- 13, , , , , , et al. The tripartite motif family identifies cell compartments. EMBO J 2001; 20: 2140–2151.
- 14, , . Discordant evolution of the adjacent antiretroviral genes TRIM22 and TRIM5 in mammals. PLoS Pathog 2007; 3: e197.
- 15, . Molecular cloning of a new interferon-induced factor that represses human immunodeficiency virus type 1 long terminal repeat expression. J Biol Chem 1995; 270: 14891–14898.
- 16, , , , , , et al. Stimulated trans-acting factor of 50 kDa (Staf50) inhibits HIV-1 replication in human monocyte-derived macrophages. Virology 2006; 356: 79–94.
- 17, , , , . Regulation of the interferon-inducible p53 target gene TRIM22 (Staf50) in human T lymphocyte activation. J Interferon Cytokine Res 2007; 27: 857–864.
- 18, , , , , , et al. Gene profiling involved in immature CD4+ T lymphocyte responsible for systemic lupus erythematosus. Mol Immunol 2006; 43: 1497–1507.
- 19, , , , , , et al. Expression profiling of Wilms tumors reveals new candidate genes for different clinical parameters. Int J Cancer 2006; 118: 1954–1962.Direct Link:
- 20, . Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 2001; 19: 65–91.
- 21, , , . Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci U S A 2004; 101: 6669–6674.
- 22, , , , , . Amplification of expression of hepatitis B surface antigen in 3T3 cells cotransfected with a dominant-acting gene and cloned viral DNA. Proc Natl Acad Sci U S A 1982; 79: 1815–1819.
- 23, , , . Identification of TRIM22 as a RING finger E3 ubiquitin ligase. Biochem Biophys Res Commun 2008; 374: 502–506.
- 24, , , . Differentiation-specific transcriptional regulation of the hepatitis B virus large surface antigen gene in human hepatoma cell lines. J Virol 1990; 64: 2360–2368.
- 25, , , . Duck hepatitis B virus (DHBV) particles produced by transient expression of DHBV DNA in a human hepatoma cell line are infectious in vitro. J Virol 1988; 62: 3513–3516.
- 26, , , , , , et al. Cutting edge: autoantigen Ro52 is an interferon inducible E3 ligase that ubiquitinates IRF-8 and enhances cytokine expression in macrophages. J Immunol 2007; 179: 26–30.
- 27, , , , , . A retrovirus restriction factor TRIM5alpha is transcriptionally regulated by interferons. Biochem Biophys Res Commun 2005; 338: 1950–1956.
- 28, , , , , , et al. Molecular cloning of ring finger protein 21 (RNF21)/interferon-responsive finger protein (ifp1), which possesses two RING-B box-coiled coil domains in tandem. Genomics 2000; 69: 143–149.
- 29, , . TRIM28 mediates primer binding site-targeted silencing of Lys1,2 tRNA-utilizing retroviruses in embryonic cells. Proc Natl Acad Sci U S A 2008; 105: 12521–12526.
- 30, , , , , , et al. Suppression of hepatitis B virus core promoter by the nuclear orphan receptor TR4. J Biol Chem 2003; 278: 9353–9360.
- 31, , , , , , et al. The transcriptional transactivation function of HBx protein is important for its augmentation role in hepatitis B virus replication. J Virol 2005; 79: 5548–5556.
- 32, , , , , , et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 2007; 446: 916–920.
- 33, , , , . Trim11 increases expression of dopamine beta-hydroxylase gene by interacting with Phox2b. Biochem Biophys Res Commun 2008; 368: 650–655.